Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil

2015 ◽  
Vol 40 (3) ◽  
pp. 345-348 ◽  
Author(s):  
B.-F. Wang ◽  
Y. Wang ◽  
B.-Y. Wang ◽  
F.-R. Sun ◽  
D. Zhang ◽  
...  
2012 ◽  
Vol 17 (1) ◽  
pp. 147-148 ◽  
Author(s):  
Homare Shimohata ◽  
Shinsuke Sakai ◽  
Yujiro Ogawa ◽  
Kouichi Hirayama ◽  
Masaki Kobayashi

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Qian Xiang ◽  
Zhiyan Liu ◽  
Yanyan Yu ◽  
Hanxu Zhang ◽  
Qiufen Xie ◽  
...  

2014 ◽  
Vol 53 (3) ◽  
pp. 233-237 ◽  
Author(s):  
Hiroyuki Eguchi ◽  
Munehisa Tsuruta ◽  
Junichi Tani ◽  
Reiichiro Kuwahara ◽  
Yuji Hiromatsu

Bone ◽  
2016 ◽  
Vol 93 ◽  
pp. 97-103 ◽  
Author(s):  
Zhe Wei ◽  
Jin-wei He ◽  
Wen-zhen Fu ◽  
Zhen-lin Zhang

2015 ◽  
Vol 6 (1) ◽  
pp. 71-75
Author(s):  
Masao Takatori ◽  
Shogo Iwabuchi ◽  
Hirohito Shimizu ◽  
Kentaro Takatsuka ◽  
Keiji Matsui ◽  
...  

Kanzo ◽  
2013 ◽  
Vol 54 (3) ◽  
pp. 187-193 ◽  
Author(s):  
Eri Kumade ◽  
Norihiro Furusyo ◽  
Fujiko Mitsumoto ◽  
Eiichi Ogawa ◽  
Kazuhiro Toyoda ◽  
...  

2015 ◽  
Vol 20 (6) ◽  
pp. 603-611 ◽  
Author(s):  
Li-Jun Xu ◽  
Yan Jiang ◽  
Ruo-Xi Liao ◽  
Hua-Bing Zhang ◽  
Jiang-Feng Mao ◽  
...  

Author(s):  
Yu Zhang ◽  
Jianfei Long ◽  
Shuangmei Tong ◽  
Wang Bin

This is the first case of adefovir dipivoxil (ADV)-induced hypophosphatemic osteomalacia (HO) and Fanconi’s syndrome in which bone mineral density (BMD) is continuously reduced after drug discontinuation. Sustained elevation of urine β2-MG also supports the recent view that ADV-induced renal injury is not completely reversible.


Sign in / Sign up

Export Citation Format

Share Document